Presynaptic kynurenate-sensitive receptors inhibit glutamate release - PubMed (original) (raw)
Presynaptic kynurenate-sensitive receptors inhibit glutamate release
R Carpenedo et al. Eur J Neurosci. 2001 Jun.
Abstract
Kynurenic acid is a tryptophan metabolite provided with antagonist activity on ionotropic glutamate and alpha7 nicotinic acetylcholine receptors. We noticed that in rats with a dialysis probe placed in the head of their caudate nuclei, local administration of kynurenic acid (30-100 nM) significantly reduced glutamate output. Qualitatively and quantitatively similar effects were observed after systemic administration of kynurenine hydroxylase inhibitors, a procedure able to increase brain kynurenate concentrations. Interestingly, in microdialysis studies, methyllycaconitine (0.3-10 nM), a selective alpha7 nicotinic receptor antagonist, also reduced glutamate output. In isolated superfused striatal synaptosomes, kynurenic acid (100 nM), but not methyllycaconitine, inhibited the depolarization (KCl 12.5 mM)-induced release of transmitter or previously taken-up [3H]-D-aspartate. This inhibition was not modified by glycine, N-methyl-D-aspartate or subtype-selective kainate receptor agents, while CNQX or DNQX (10 microM), two AMPA and kainate receptor antagonists, reduced kynurenic acid effects. Low concentrations of kynurenic acid, however, did not modify [3H]-kainate (high and low affinity) or [3H]-AMPA binding to rat brain membranes. Finally, because metabotropic glutamate (mGlu) receptors modulate transmitter release in striatal preparations, we evaluated, with negative results, kynurenic acid (1-100 nM) effects in cells transfected with mGlu1, mGlu2, mGlu4 or mGlu5 receptors. In conclusion, our data show that kynurenate-induced inhibition of glutamate release is not mediated by glutamate receptors. Nicotinic acetylcholine receptors, however, may contribute to the inhibitory effects of kynurenate found in microdialysis studies, but not in those found in isolated synaptosomes.
Similar articles
- alpha-bungarotoxin-sensitive nicotinic receptors indirectly modulate [(3)H]dopamine release in rat striatal slices via glutamate release.
Kaiser S, Wonnacott S. Kaiser S, et al. Mol Pharmacol. 2000 Aug;58(2):312-8. doi: 10.1124/mol.58.2.312. Mol Pharmacol. 2000. PMID: 10908298 - Modulation of the function of presynaptic alpha7 and non-alpha7 nicotinic receptors by the tryptophan metabolites, 5-hydroxyindole and kynurenate in mouse brain.
Grilli M, Raiteri L, Patti L, Parodi M, Robino F, Raiteri M, Marchi M. Grilli M, et al. Br J Pharmacol. 2006 Nov;149(6):724-32. doi: 10.1038/sj.bjp.0706914. Epub 2006 Oct 3. Br J Pharmacol. 2006. PMID: 17016503 Free PMC article. - Does kynurenic acid act on nicotinic receptors? An assessment of the evidence.
Stone TW. Stone TW. J Neurochem. 2020 Mar;152(6):627-649. doi: 10.1111/jnc.14907. Epub 2019 Nov 24. J Neurochem. 2020. PMID: 31693759 Free PMC article. Review. - Kynurenic acid as an antagonist of α7 nicotinic acetylcholine receptors in the brain: facts and challenges.
Albuquerque EX, Schwarcz R. Albuquerque EX, et al. Biochem Pharmacol. 2013 Apr 15;85(8):1027-32. doi: 10.1016/j.bcp.2012.12.014. Epub 2012 Dec 25. Biochem Pharmacol. 2013. PMID: 23270993 Free PMC article. Review.
Cited by
- New insight into the antidepressants action: modulation of kynurenine pathway by increasing the kynurenic acid/3-hydroxykynurenine ratio.
Kocki T, Wnuk S, Kloc R, Kocki J, Owe-Larsson B, Urbanska EM. Kocki T, et al. J Neural Transm (Vienna). 2012 Feb;119(2):235-43. doi: 10.1007/s00702-011-0668-8. Epub 2011 Jun 10. J Neural Transm (Vienna). 2012. PMID: 21660485 - Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid.
Justinova Z, Mascia P, Wu HQ, Secci ME, Redhi GH, Panlilio LV, Scherma M, Barnes C, Parashos A, Zara T, Fratta W, Solinas M, Pistis M, Bergman J, Kangas BD, Ferré S, Tanda G, Schwarcz R, Goldberg SR. Justinova Z, et al. Nat Neurosci. 2013 Nov;16(11):1652-61. doi: 10.1038/nn.3540. Epub 2013 Oct 13. Nat Neurosci. 2013. PMID: 24121737 Free PMC article. - Differential Levels of Tryptophan-Kynurenine Pathway Metabolites in the Hippocampus, Anterior Temporal Lobe, and Neocortex in an Animal Model of Temporal Lobe Epilepsy.
Dey S, Dubey V, Dixit AB, Tripathi M, Chandra PS, Banerjee J. Dey S, et al. Cells. 2022 Nov 10;11(22):3560. doi: 10.3390/cells11223560. Cells. 2022. PMID: 36428989 Free PMC article. - Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's disease.
Rodrigues FB, Byrne LM, Lowe AJ, Tortelli R, Heins M, Flik G, Johnson EB, De Vita E, Scahill RI, Giorgini F, Wild EJ. Rodrigues FB, et al. J Neurochem. 2021 Jul;158(2):539-553. doi: 10.1111/jnc.15360. Epub 2021 May 5. J Neurochem. 2021. PMID: 33797782 Free PMC article. - Systemic L-Kynurenine sulfate administration disrupts object recognition memory, alters open field behavior and decreases c-Fos immunopositivity in C57Bl/6 mice.
Varga D, Herédi J, Kánvási Z, Ruszka M, Kis Z, Ono E, Iwamori N, Iwamori T, Takakuwa H, Vécsei L, Toldi J, Gellért L. Varga D, et al. Front Behav Neurosci. 2015 Jun 16;9:157. doi: 10.3389/fnbeh.2015.00157. eCollection 2015. Front Behav Neurosci. 2015. PMID: 26136670 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources